Blog Read the latest perspectives from our team of subject matter experts and others Trials, Data, Diversity – H1’s Top 5 Diagnoses (Predictions) for Biotech and Pharma in 2024How will AI impact clinical trials? Will FDA legislation improve diversity? What platforms will key opinion leaders adopt? Every year, we take a look at annual predictions to help life… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development Global Impact HCP Volunteers KOL Engagement Provider Data Research Post Industries:Commercialization Global Impact Payors Pharmaceutical & Biotechnology Provider Data Research ResearchThe COVID-19 Essential Reading CollectionThe next collection in our series of Faculty Opinions Essential Reading that we want to highlight is COVID-19. When the COVID-19 pandemic arrived, it disrupted nearly every aspect of our… Continue reading → Read the article Diversity & InclusionHow to Build a Scalable Diversity StrategyPut simply – in 2022, clinical trial diversity, equity and inclusion (DEI) was top of mind for the pharma and biotech industries, across all phases of drug and device… Continue reading → Read the articleno ResearchResearch Collection: Alzheimer’s DiseaseWe’re delighted to launch the second Faculty Opinions Essential Reading collection: Alzheimer’s. Millions of people worldwide live with dementia, including Alzheimer’s. Our Faculty finds and assesses the literature to highlight the… Continue reading → Read the article KOL EngagementTis the Season…for Conference PlanningAs we come out of the holidays , in the United States, some of the greatest minds in medicine and healthcare are gathered this week at the JP Morgan Healthcare… Continue reading → Read the articleno ResearchResearch Collection: Opioid AddictionWe’re delighted to launch the fourth Faculty Opinions Essential Reading collection: Opioid Addiction. “Opioid abuse and addiction are major global health issues today. This collection aims to collate notable research… Continue reading → Read the articleno Diversity & InclusionDrug DevelopmentThree Essential Data Insights for Optimal Trial Site Feasibility, Inclusivity and SelectionWhen you google the term “clinical trial,” the first thing that comes up is the National Library of Medicine site all about clinical research. It’s a great foray and… Continue reading → Read the articleno«‹45678910›»